Equalizing access to innovative treatments across MERAT
About Us
Since 2013, Inpharmus has been delivering innovative pharmaceutical solutions that bridge global manufacturers with local healthcare markets. With a strong focus on quality, compliance, and long-term partnerships, we bring trusted treatments closer to the patients who need them most.
Rare Diseases
Diseases that affect a small percentage of people compared to the general population are known as rare diseases. Specific problems arise in these disorders due to their rare occurrence. While a disease can be rare in one region, it may be common in another.
To date, more than 7,000 rare diseases have been identified, and this number continues to grow.
Oncology
Starting from the in-utero stage of life, a complex regulatory system controls the growth, maturation, proliferation, and death of each cell in the human body. Cancer results from the accumulation of genetic damage in these regulatory mechanisms at the cellular level, leading to the uncontrolled growth of dysfunctional or non-functional cells in a specific part of the body. While cancer may occur in any tissue and organ, and many different types of cancer can arise from the same tissue, all cancers share a common feature: uncontrolled, abnormal cell division.
Hematology
The hematologic system plays a vital role in oxygen transport, immune defense, coagulationand cellular homeostasis. Disorders affecting this system may arise from defects in blood cellproduction, proliferation, differentiation or immune regulation. The clinical spectrum rangesfrom acquired conditions to genetically driven immune dysregulation syndromes that requireadvanced and multidisciplinary care.
Rare Diseases
Diseases that affect a small percentage of people compared to the general population are known as rare diseases. Specific problems arise in these disorders due to their rare occurrence. While a disease can be rare in one region, it may be common in another.
To date, more than 7,000 rare diseases have been identified, and this number continues to grow.
Oncology
Starting from the in-utero stage of life, a complex regulatory system controls the growth, maturation, proliferation, and death of each cell in the human body. Cancer results from the accumulation of genetic damage in these regulatory mechanisms at the cellular level, leading to the uncontrolled growth of dysfunctional or non-functional cells in a specific part of the body. While cancer may occur in any tissue and organ, and many different types of cancer can arise from the same tissue, all cancers share a common feature: uncontrolled, abnormal cell division.
Hematology
The hematologic system plays a vital role in oxygen transport, immune defense, coagulationand cellular homeostasis. Disorders affecting this system may arise from defects in blood cellproduction, proliferation, differentiation or immune regulation. The clinical spectrum rangesfrom acquired conditions to genetically driven immune dysregulation syndromes that requireadvanced and multidisciplinary care.
Explore Markets
Inpharmus has an established presence in each of the territories shown on this interactive map.
Click on a region to learn more about our regional operations and the local market opportunities we can help you access.